Luzerner Kantonsspital

Futó vizsgálatok

• Toboroz

  Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT07149649· 2/3. fázis· Forrás

• Toboroz

  Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

  NCT07829081· Forrás

• Még nem toboroz

  FAPI PET Imaging - An Exploratory Study

  NCT07705074· 1/2. fázis· Forrás

• Toboroz

  Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

  NCT07365423· 2. fázis· Forrás

• Meghívásos bevonás

  Comparison of Blended Care Outpatient Neurorehabilitation With Traditional Outpatient Neurorehabilitation

  NCT07458308· Forrás

• Toboroz

  Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

  NCT07256704· Forrás

• Toboroz

  Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial

  NCT07263438· 2. fázis· Forrás

• Toboroz

  Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  NCT06765109· 3. fázis· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· 3. fázis· Forrás

• Toboroz

  T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer

  NCT07581496· Forrás

• Toboroz

  A Space-expanding Shield in Decompressive Hemicraniectomy for Stroke

  NCT06638385· Forrás

• Toboroz

  Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer

  NCT07617610· Forrás

• Toboroz

  Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

  NCT05815927· 3. fázis· Forrás

• Meghívásos bevonás

  A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

  NCT07055607· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  NCT06790693· 3. fázis· Forrás

• Toboroz

  Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

  NCT06571149· 4. fázis· Forrás

• Fut, nem toboroz

  REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

  NCT06557798· Forrás

• Toboroz

  Skin Cancer and Hyperthermia and Radiotherapy

  NCT06384053· Forrás

• Toboroz

  Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  NCT06401980· 2. fázis· Forrás

• Toboroz

  Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

  NCT05976685· Forrás

• Toboroz

  Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients

  NCT06114108· Forrás

• Toboroz

  New Interactive Sensor-home-based Hand Training to Improve Dexterity

  NCT06062693· Forrás

• Fut, nem toboroz

  Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

  NCT05705973· Forrás

• Fut, nem toboroz

  Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC

  NCT04630730· 2. fázis· Forrás

• Toboroz

  A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

  NCT05384626· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

  NCT04965493· 3. fázis· Forrás

• Fut, nem toboroz

  Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

  NCT04763200· Forrás

• Fut, nem toboroz

  Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

  NCT04608318· 3. fázis· Forrás

• Toboroz

  MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

  NCT04111978· 3. fázis· Forrás

• Fut, nem toboroz

  Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

  NCT03947619· Forrás

• Toboroz

  Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

  NCT04300257· Forrás

• Toboroz

  CARDSUP - SWISS Circulatory Support Registry

  NCT04117230· Forrás

• Toboroz

  Swiss Primary Biliary Cholangitis Cohort Study

  NCT03146910· Forrás

• Fut, nem toboroz

  Prostate Cancer Biobank

  NCT04024475· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Stroke (szélütés)6 toboroz
• Tüdőrák5 toboroz
• Prosztatarák3 toboroz
• Elhízás2 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyermekkori daganatok2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Hólyagrák2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Vastagbélrák2 toboroz
• Áttétes emlőrák1 toboroz
• Endometriózis1 toboroz
• Glioblasztóma1 toboroz
• Hasnyálmirigyrák1 toboroz
• Máj- és epeúti rák1 toboroz
• Melanóma1 toboroz
• Mezotelióma1 toboroz
• Mielóma multiplex1 toboroz
• Pajzsmirigyrák1 toboroz
• Parkinson-kór1 toboroz
• Petefészekrák1 toboroz
• Pitvarfibrilláció1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Szarkóma1 toboroz
• Szívelégtelenség1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Visszavonták

  A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

  NCT07357766· 3. fázis· Forrás

• Lezárult

  SpinChip Hs-cTnI Clinical Diagnostic Performance

  NCT06499519· Forrás

• Lezárult

  Emp-Activity: Empagliflozin Functional Capacity

  NCT05350202· Forrás

• Lezárult

  Neurostatus-SMARTCARE in Comparison to Standard Neurostatus-EDSS®

  NCT05575843· Forrás

• Lezárult

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

  NCT05259033· 3. fázis· Forrás

• Lezárult

  A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

  NCT06734117· Forrás

• Leállították

  External Validation of Two Prediction Models for Independent Gait After Stroke

  NCT05039047· Forrás

• Lezárult

  Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

  NCT04864795· Forrás

• Lezárult

  Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

  NCT06830408· Forrás

• Lezárult

  BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

  NCT03762018· 3. fázis· Forrás

• Leállították

  Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

  NCT03708003· 2. fázis· Forrás

• Lezárult

  Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

  NCT03048825· 3. fázis· Forrás

• Lezárult

  Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma

  NCT03297593· 2. fázis· Forrás

• Lezárult

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· 3. fázis· Forrás

• Lezárult

  Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)

  NCT02572843· 2. fázis· Forrás

• Leállították

  Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

  NCT02051218· 3. fázis· Forrás

• Lezárult

  ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

  NCT02078427· Forrás